Virology (GBV-C)

New Virus Not Etiologic Factor in non-A-E Fulminant Hepatitis

Published in Hepatitis Weekly, June 30th, 1997

A Japanese study suggests that GBV-C is not a major etiologic agent for non-A-E fulminant hepatitis.

The study, reported by Tatsuo Kanda and colleagues, agrees with many other recent reports finding no clinical impact for the newly discovered hepatitis G virus (HGV) or GBV-C ("Detection of GBV-C RNA in Patients with Non-A-E Fulminant Hepatitis by Reverse-Transcription Polymerase Chain Reaction," Hepatology, June 1997;25(5):1261-1266).

Fulminant hepatitis is characterized by severe liver damage, hepatic encephalopathy, and high mortality. Fulminant hepatic failure was originally defined as the development of hepatic encephalopathy within eight weeks...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1997-06-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry